Skip to content
PreclinicalResearch compoundModerate evidence

Pramiracetam

Potent cholinergic racetam, HACU enhancement + AMPA modulation.

NootropicRacetamMemoryFocusCholinergicAcetylcholineAMPA

Pharmacology

ClassRacetam · Memory · Focus · Cholinergic
Primary targetHigh-affinity choline transporter CHT1 (HACU)
Targets3 receptor targets
EvidenceModerate evidence
Affected systemsAcetylcholineAMPA

Contents

Related comparisons

Pramiracetam vs Coluracetam

WHAT IS PRAMIRACETAM?

Detailed overview

Pramiracetam is a high-potency Piracetam analog whose primary action is facilitation of hippocampal high-affinity choline uptake (HACU) – showing a 30-37% increase in ACh turnover in vivo, with a bell-shaped dose-response curve (lower doses often work better). It does NOT modulate GABA, dopamine, noradrenaline, or serotonin – a pure cholinergic profile. Orally well-bioavailable (~4-5 h half-life). Chronic corticosteroid elevation (stress) can block its memory-enhancing effect (PMID 1410129). The typical dose (300-600 mg) is far lower than Piracetam`s. It was prescription-only in Italy as Pramistar; currently withdrawn in several markets.

Mechanism

HACU + AMPA

Half-life

4-6 h

Legal status

EU Rx (IT, withdrawn)

Receptor profile

  • Choline transporter CHT1 (HACU)Strong
  • Cerebral blood flowModerate
  • AMPA glutamate receptorWeak

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Headache, often due to choline depletion (well mitigated by a choline source such as alpha-GPC or CDP-choline)
  • Irritability and tension (the most frequently reported side effect)
  • Brain fog and mental dullness, typically with inadequate choline
  • Tiredness and fatigue
  • Tolerance development with prolonged, uninterrupted use
  • Nervousness or mild restlessness, especially at higher doses

Contraindications · 5

  • Pregnancy and breastfeeding: no safety data, should be avoided
  • Severe renal or hepatic impairment: caution, as clearance may be affected
  • Concurrent cholinergic drugs (e.g. cholinesterase inhibitors): cholinergic effects may be additive
  • Inadequate choline intake: increases risk of headache and brain fog, a choline source is advised
  • Chronic stress with elevated corticosteroids: may block the memory-enhancing effect

Related Nootropics

Same therapeutic category

FAQ

FAQ

Pramiracetam is a stronger, cholinergic-type relative of piracetam, developed mainly to boost the brain's acetylcholine turnover, the messenger chemical that plays a key role in memory and learning. According to the description, it helps facilitate choline uptake in the brain and may also influence glutamatergic (AMPA) signaling, which in theory could support better focus and memory performance. The source doesn't list specific, concrete benefits, so nothing more definite can be said based on the available data.

Telegram

Have a question about Pramiracetam?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC14H27N3O2
UpdatedJune 19, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.